Advancing PoC Devices for Early Disease Detection using Graphene-based Sensors

Early detection of diseases is key to better disease management and higher survival rates. It aims at discovering conditions that have already produced biochemical changes in body fluids, but have not yet reached a stage of apparent physical symptoms or medical emergency. Therefore, early disease detection relies majorly on biochemical testing of biological fluids such as serum, in the body. The laboratories for these tests require biochemical-based instrumentations that are bulky and not commonly available especially in developing countries. Moreover, the tests are expensive and require trained personnel to conduct and interpret results. On the other hand, Lab-on-a-Chip (LOC) biosensors have a potential to miniaturize the entire biochemical/laboratory methods of diagnostics into versatile, inexpensive and portable devices with great potential for low-cost Point-of-Care (POC) applications. They are capable of providing accurate and precise information on the measured health indices for sub-clinical level of diseases. Nanotechnology-inspired biosensors have further advantages of low limit of detection (required for early diagnosis), real-time analysis and lesser sample volume requirement. Of all other nanomaterials, graphene is said to be the most promising, suitable for biosensing due to its biocompatibility and consistent signal amplification even under the conditions of harsh ionic solutions found in the human body. This paper reviews the potentials, fundamental concepts and related works in using Graphene-based Field Effect Transistors (GFETs) as biosensors for early disease diagnosis. This paper also highlights a low-cost patterning mechanism for preparing SiO2/Si substrate for metal deposition (of the source and drain electrodes of FETs)